INNV logo

InnovAge Holding Corp. (INNV)

Profile

Full Name

InnovAge Holding Corp.

Ticker

NASDAQ: INNV

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Care Facilities

Country

United States

IPO

March 4, 2021

Indexes

Not included

Website

https://www.innovage.com

Employees

2350

Key Details

Price

$4.03(+6.33%)

Market cap

$544.10M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$763.86M(+11.01% YoY)

Annual EPS

-$0.16(+46.67% YoY)

PE ratio

-

Next earnings date

Sep 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $4.03
    INNV price is $4.03

    30-Day Relative Volume

    1.43
    INNV 30-day relative volume is 1.43

    Price Performance

    Price Most recent change

    +6.33%
    INNV price was up +6.33% on Sep 8, 2025

    Price YTD change

    +2.54%
    INNV price is up +2.54% since January 1st

    Price 1-year change

    -35.83%
    INNV price is down -35.83% year-on-year

    Price 3-year change

    +6.33%
    INNV price is up +6.33% over the past 3 years

    Price Range

    Price All-time high

    $27.18
    INNV price is currently -85.17% below its historical high of $27.18

    Price 3-year low

    $2.60
    INNV price is currently +55.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $544.10M
    INNV market capitalization is $544.10 million

    Market cap 3-year change

    +5.92%
    INNV market capitalization is up +5.92% over the past 3 years

    Market cap All-time high

    $3.53B
    INNV market capitalization is currently -84.58% below its historical high of $3.53 billion

    Market cap sector rank

    65.41%
    INNV market capitalization is higher than 65.41% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -0.81%
    INNV shares outstanding is down -0.81% year-on-year

    Shares Outstanding 3-Year Change

    -0.38%
    INNV shares outstanding is down -0.38% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.11
    INNV beta is 1.11

    200-day SMA

    $3.70
    INNV price is currently +8.85% above its 200-day simple moving average

    50-day SMA

    $3.78
    INNV price is currently +6.53% above its 50-day simple moving average

    RSI

    59.55
    INNV 14-day relative strength index is 59.55

    Volume

    1.43
    INNV 30-day relative volume is 1.43

    ATR

    $0.26
    INNV average true range is $0.26

    10-day Historical Volatility

    59.78%
    INNV 10-day historical volatility is 59.78%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $763.86M
    INNV annual revenue is $763.86 million

    Revenue Analysts estimate

    $852.01M
    INNV annual revenue is currently -10.35% lower than the consensus analysts' forecast

    Revenue 1-year change

    +11.01%
    INNV annual revenue is up +11.01% year-on-year

    Revenue Sector rank

    84.11%
    INNV annual revenue is higher than 84.11% of companies in Healthcare sector

    EPS

    EPS

    -$0.16
    INNV annual earnings per share is -$0.16

    EPS Analysts estimate

    $0.03
    INNV annual earnings per share is currently -633.33% lower than the consensus analysts' forecast

    EPS 1-year change

    +46.67%
    INNV annual earnings per share is up +46.67% year-on-year

    EPS Sector rank

    71.93%
    INNV annual earnings per share is higher than 71.93% of companies in Healthcare sector

    Profit

    Gross profit

    $113.11M
    INNV annual gross profit is $113.11 million

    Gross margin

    14.81%
    INNV annual gross profit margin is 14.81%

    Operating profit

    -$17.22M
    INNV annual operating income is -$17.22 million

    Operating margin

    -2.25%
    INNV annual operating profit margin is -2.25%

    Net income

    -$23.22M
    INNV annual net profit is -$23.22 million

    Net margin

    -3.04%
    INNV annual net profit margin is -3.04%

    Expenses

    Total expenses

    $785.19M
    INNV annual total expenses is $785.19 million

    Operating expenses

    $130.34M
    INNV annual total operating expenses is $130.34 million

    Cost of goods sold

    $650.74M
    INNV annual cost of goods sold is $650.74 million

    Selling, general & administrative expenses

    $136.29M
    INNV annual SGA is $136.29 million

    Depreciation and amortization

    $18.95M
    INNV annual depreciation & amortization is $18.95 million

    Interest expense

    $0.00
    INNV annual interest expense is $0.00

    Income tax

    $1.40M
    INNV annual income tax is $1.40 million

    EBIT & EBITDA

    EBIT

    -$17.22M
    INNV annual earnings before interest & taxes is -$17.22 million

    EBITDA

    $1.73M
    INNV annual EBITDA is $1.73 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $579.84M
    INNV annual total assets is $579.84 million

    Non current assets

    $374.52M
    INNV annual long term assets is $374.52 million

    Current assets

    $173.14M
    INNV annual total current assets is $173.14 million

    Cash and cash equivalents

    $56.95M
    INNV annual cash & cash equivalents is $56.95 million

    Accounts receivable

    $48.11M
    INNV annual accounts receivable is $48.11 million

    Inventory

    $0.00
    INNV annual inventory is $0.00

    Liabilities

    Total liabilities

    $280.03M
    INNV annual total liabilities is $280.03 million

    Long term liabilities

    $109.25M
    INNV annual total long term liabilities is $109.25 million

    Current liabilities

    $138.60M
    INNV annual total current liabilities is $138.60 million

    Accounts payable

    $55.46M
    INNV annual accounts payable is $55.46 million

    Debt

    Total debt

    $113.03M
    INNV annual total debt is $113.03 million

    Total debt 1-year change

    +3.86%
    INNV annual total debt is up +3.86% year-on-year

    Long term debt

    $100.50M
    INNV annual long term debt is $100.50 million

    Short term debt

    $12.54M
    INNV annual short term debt is $12.54 million

    Equity & Capital

    Shareholders equity

    $269.26M
    INNV annual stockholders equity is $269.26 million

    Book value

    $269.26M
    INNV annual book value is $269.26 million

    Retained earnings

    -$68.31M
    INNV annual retained earnings is -$68.31 million

    Working capital

    $34.54M
    INNV annual working capital is $34.54 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$36.90M
    INNV annual cash flow from operations is -$36.90 million

    Cash from operations 1-year change

    -282.34%
    INNV annual cash flow from operations is down -282.34% year-on-year

    Cash from investing

    -$26.37M
    INNV annual cash flow from investing activities is -$26.37 million

    Cash from investing 1-year change

    +62.06%
    INNV annual cash flow from investing activities is up +62.06% year-on-year

    Cash from financing

    -$7.03M
    INNV annual cash flow from financing activities is -$7.03 million

    Cash from financing 1-year change

    +10.92%
    INNV annual cash flow from financing activities is up +10.92% year-on-year

    CAPEX

    CAPEX

    $7.91M
    INNV annual capital expenditures is $7.91 million

    CAPEX 1-year change

    -66.11%
    INNV annual capital expenditures is down -66.11% year-on-year

    Free Cash Flow

    Free cash flow

    -$44.81M
    INNV annual free cash flow is -$44.81 million

    Free cash flow 1-year change

    -1337.2%
    INNV annual free cash flow is down -1337.2% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    14.81%
    INNV annual gross profit margin is 14.81%

    Operating margin

    -2.25%
    INNV annual operating profit margin is -2.25%

    Net margin

    -3.04%
    INNV annual net profit margin is -3.04%

    ROA & ROE

    ROA

    -3.96%
    INNV annual return on assets is -3.96%

    ROE

    -7.56%
    INNV annual return on equity is -7.56%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    INNV price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    INNV price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.29
    INNV price to book ratio is 2.29

    PB ratio Sector rank

    56.65%
    INNV price to book ratio is higher than 56.65% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.65
    INNV price to sales ratio is 0.65

    PS ratio Sector rank

    14.02%
    INNV price to sales ratio is higher than 14.02% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $547.75M
    INNV enterprise value is $547.75 million

    Enterprise value Sector rank

    66.13%
    INNV enterprise value is higher than 66.13% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    27.61
    INNV EV/EBITDA is 27.61

    EV/EBITDA Sector rank

    93.46%
    INNV EV/EBITDA is higher than 93.46% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.25
    INNV annual current ratio is 1.25

    Quick ratio

    1.25
    INNV annual quick ratio is 1.25

    Leverage

    Debt to equity

    0.42
    INNV annual debt to equity ratio is 0.42

    Interest coverage ratio

    -
    INNV annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    6
    INNV piotroski f-score is 6

    Altman Z-Score

    2.29
    INNV altman z-score is 2.29

    Analyst ratings

    Recent major analysts updates

    Dec 17, 24 JP Morgan
    Underweight
    Mar 13, 24 JP Morgan
    Neutral
    Feb 8, 24 Goldman Sachs
    Neutral
    Feb 15, 23 Goldman Sachs
    Neutral
    Feb 8, 23 JP Morgan
    Neutral
    Nov 23, 22 Goldman Sachs
    Neutral
    Nov 16, 22 Citigroup
    Neutral
    Sep 15, 22 Barclays
    Equal-Weight
    May 16, 22 Baird
    Neutral
    May 11, 22 Piper Sandler
    Underweight

    Institutional Ownership

    Screeners with INNV included

    US stocks
    High Piotroski score stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks recommended to hold
    Earnings today
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for InnovAge Holding Corp.?
    • Does InnovAge Holding Corp. pay dividends?
    • What sector is InnovAge Holding Corp. in?
    • What industry is InnovAge Holding Corp. in?
    • What country is InnovAge Holding Corp. based in?
    • When did InnovAge Holding Corp. go public?
    • Is InnovAge Holding Corp. in the S&P 500?
    • Is InnovAge Holding Corp. in the NASDAQ 100?
    • Is InnovAge Holding Corp. in the Dow Jones?
    • When was InnovAge Holding Corp.'s last earnings report?
    • When does InnovAge Holding Corp. report earnings?

    What is the ticker symbol for InnovAge Holding Corp.?

    The ticker symbol for InnovAge Holding Corp. is NASDAQ:INNV

    Does InnovAge Holding Corp. pay dividends?

    No, InnovAge Holding Corp. does not pay dividends

    What sector is InnovAge Holding Corp. in?

    InnovAge Holding Corp. is in the Healthcare sector

    What industry is InnovAge Holding Corp. in?

    InnovAge Holding Corp. is in the Medical Care Facilities industry

    What country is InnovAge Holding Corp. based in?

    InnovAge Holding Corp. is headquartered in United States

    When did InnovAge Holding Corp. go public?

    InnovAge Holding Corp.'s initial public offering (IPO) was on March 4, 2021

    Is InnovAge Holding Corp. in the S&P 500?

    No, InnovAge Holding Corp. is not included in the S&P 500 index

    Is InnovAge Holding Corp. in the NASDAQ 100?

    No, InnovAge Holding Corp. is not included in the NASDAQ 100 index

    Is InnovAge Holding Corp. in the Dow Jones?

    No, InnovAge Holding Corp. is not included in the Dow Jones index

    When was InnovAge Holding Corp.'s last earnings report?

    InnovAge Holding Corp.'s most recent earnings report was on May 6, 2025

    When does InnovAge Holding Corp. report earnings?

    The next expected earnings date for InnovAge Holding Corp. is September 9, 2025
    On this page